Back to search

Article

BET Protein Inhibition Evidently Enhances Sensitivity to PI3K/mTOR Dual Inhibition in Intrahepatic Cholangiocarcinoma

2021-06-21

Abstract excerpt

<h4>Background: </h4> & Aims: Intrahepatic cholangiocarcinoma (ICC), the second most common primary liver cancer, is a fatal malignancy with a poor prognosis. Molecular targeted therapy is a promising treatment strategy. However, resistance to molecular-targeted therapy is inevitable and represents a major clinical challenge. Our objective was to provide a novel and efficient therapeutic strategy in treating prima...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7bf3f0d1-2796-57bb-a4ff-7fc5dccf468b
DOI
10.21203/rs.3.rs-616430/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
BET Protein Inhibition Evidently Enhances Sensitivity to PI3K/mTOR Dual Inhibition in Intrahepatic CholangiocarcinomaDOI 10.21203/rs.3.rs-616430/v1
Select a neighboring publication to make it the new centre.